A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple sclerosis (MS).
Emily Henders, 37, from Bushey, Hertfordshire, was treated at University College London Hospital (UCLH) as part of a global clinical trial.
Mrs Henders had experienced "really scary" relapse episodes since being diagnosed in December 2021 during which, she said: "My legs don't work, I can't walk."
Experts believe the targeted immunotherapy treatment could "transform" lives by slowing or even halting progression of the disease.
"I hope taking part in the trial means I will never have to experience another relapse and that my MS symptoms will not progress," Mrs Henders said.
